Study Links Uric Acid and Red Blood Cells to Severe Obstructive Sleep Apnea
Obstructive sleep apnea-hypopnea syndrome (OSAHS) is a prevalent sleep-related breathing disorder that significantly impacts health. A recent study aimed to explore the association between hematological parameters, specifically uric acid and red blood cell distribution width (RDW), and the severity of OSAHS in middle-aged males. Conducted at the Second Hospital of Lanzhou University in China, the study included 132 male patients aged 40 to 65 years, diagnosed with OSAHS through polysomnography, the gold standard for diagnosis. Participants were categorized into non-severe and severe groups based on their apnea-hypopnea index (AHI). The study revealed that patients with severe OSAHS exhibited significantly higher levels of hemoglobin, hematocrit, mean corpuscular volume, RDW, and uric acid compared to those in the non-severe group. Multivariate logistic regression analysis indicated that uric acid was the only independent factor significantly associated with severe OSAHS. The combination of uric acid and RDW demonstrated a promising discriminative performance for identifying severe cases, with an area under the curve (AUC) of 0.79. The study also found that uric acid levels correlated negatively with sleep oxygen saturation, suggesting its potential role in assessing sleep hypoxia. These findings highlight the importance of uric acid and RDW as clinical markers in evaluating OSAHS severity, though further prospective studies are needed to validate these results. The research underscores the need for accessible biomarkers to aid in the diagnosis and management of OSAHS, particularly in settings where polysomnography may not be readily available.




